Cargando…
Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis
Endometriosis is a common gynaecological disease associated with pelvic pain and infertility. Current treatments include oral contraceptives combined with nonsteroidal anti-inflammatory drugs or surgery to remove lesions, all of which provide a temporary but not complete cure. Here we identify an en...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109024/ https://www.ncbi.nlm.nih.gov/pubmed/25047118 http://dx.doi.org/10.1038/ncomms5478 |
_version_ | 1782327826818531328 |
---|---|
author | Sugihara, K. Kobayashi, Y. Suzuki, A. Tamura, N. Motamedchaboki, K. Huang, C.-T. Akama, T.O. Pecotte, J. Frost, P. Bauer, C. Jimenez, J.B. Nakayama, J. Aoki, D. Fukuda, M.N. |
author_facet | Sugihara, K. Kobayashi, Y. Suzuki, A. Tamura, N. Motamedchaboki, K. Huang, C.-T. Akama, T.O. Pecotte, J. Frost, P. Bauer, C. Jimenez, J.B. Nakayama, J. Aoki, D. Fukuda, M.N. |
author_sort | Sugihara, K. |
collection | PubMed |
description | Endometriosis is a common gynaecological disease associated with pelvic pain and infertility. Current treatments include oral contraceptives combined with nonsteroidal anti-inflammatory drugs or surgery to remove lesions, all of which provide a temporary but not complete cure. Here we identify an endometriosis-targeting peptide that is internalized by cells, designated z13, using phage display. As most endometriosis occurs on organ surfaces facing the peritoneum, we subtracted a phage display library with female mouse peritoneum tissue and selected phage clones by binding to human endometrial epithelial cells. Proteomics analysis revealed the z13 receptor as the cyclic nucleotide-gated channel β3, a sorting pathway protein. We then linked z13 with an apoptosis-inducing peptide and with an endosome-escaping peptide. When these peptides were co-administered into the peritoneum of baboons with endometriosis, cells in lesions selectively underwent apoptosis with no effect on neighbouring organs. Thus, this study presents a strategy that could be useful to treat peritoneal endometriosis in humans. |
format | Online Article Text |
id | pubmed-4109024 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Pub. Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-41090242014-08-15 Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis Sugihara, K. Kobayashi, Y. Suzuki, A. Tamura, N. Motamedchaboki, K. Huang, C.-T. Akama, T.O. Pecotte, J. Frost, P. Bauer, C. Jimenez, J.B. Nakayama, J. Aoki, D. Fukuda, M.N. Nat Commun Article Endometriosis is a common gynaecological disease associated with pelvic pain and infertility. Current treatments include oral contraceptives combined with nonsteroidal anti-inflammatory drugs or surgery to remove lesions, all of which provide a temporary but not complete cure. Here we identify an endometriosis-targeting peptide that is internalized by cells, designated z13, using phage display. As most endometriosis occurs on organ surfaces facing the peritoneum, we subtracted a phage display library with female mouse peritoneum tissue and selected phage clones by binding to human endometrial epithelial cells. Proteomics analysis revealed the z13 receptor as the cyclic nucleotide-gated channel β3, a sorting pathway protein. We then linked z13 with an apoptosis-inducing peptide and with an endosome-escaping peptide. When these peptides were co-administered into the peritoneum of baboons with endometriosis, cells in lesions selectively underwent apoptosis with no effect on neighbouring organs. Thus, this study presents a strategy that could be useful to treat peritoneal endometriosis in humans. Nature Pub. Group 2014-07-22 /pmc/articles/PMC4109024/ /pubmed/25047118 http://dx.doi.org/10.1038/ncomms5478 Text en Copyright © 2014, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Sugihara, K. Kobayashi, Y. Suzuki, A. Tamura, N. Motamedchaboki, K. Huang, C.-T. Akama, T.O. Pecotte, J. Frost, P. Bauer, C. Jimenez, J.B. Nakayama, J. Aoki, D. Fukuda, M.N. Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis |
title | Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis |
title_full | Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis |
title_fullStr | Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis |
title_full_unstemmed | Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis |
title_short | Development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis |
title_sort | development of pro-apoptotic peptides as potential therapy for peritoneal endometriosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109024/ https://www.ncbi.nlm.nih.gov/pubmed/25047118 http://dx.doi.org/10.1038/ncomms5478 |
work_keys_str_mv | AT sugiharak developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis AT kobayashiy developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis AT suzukia developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis AT tamuran developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis AT motamedchabokik developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis AT huangct developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis AT akamato developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis AT pecottej developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis AT frostp developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis AT bauerc developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis AT jimenezjb developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis AT nakayamaj developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis AT aokid developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis AT fukudamn developmentofproapoptoticpeptidesaspotentialtherapyforperitonealendometriosis |